H30.813
Harada's disease, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Harada's disease, bilateral, is an uncommon inflammatory condition that affects both eyes. It is characterized by inflammation of the choroid, the middle layer of the eye, which can lead to vision disturbances. This disease often involves the uvea, the middle eye structure, and can be associated with systemic symptoms. Recognizing the signs early and understanding its features can help in seeking appropriate medical care to preserve vision and manage inflammation effectively.
Causes & Symptoms
Clinical Causes: The exact cause of Harada's disease remains unknown, but it is believed to involve an autoimmune response where the body's immune system mistakenly attacks eye tissues. Genetic factors may predispose certain individuals to develop the disease. Environmental triggers, such as infections or stress, could potentially play a role in triggering the immune response. It is more common in young to middle-aged adults, especially those from Asian and Pacific Islander backgrounds.
Key Symptoms: Blurred vision or sudden loss of visual clarity Night vision difficulties Floaters or spots in the visual field Darkening or loss of vision in the central or peripheral parts of the eye Eye pain or discomfort, often accompanied by redness Sensitivity to light (photophobia) Systemic manifestations, such as headache, fever, or malaise, indicating systemic inflammation
Diagnostic & Treatment
Diagnosis Path: Diagnosing bilateral Harada's disease involves a comprehensive eye examination and medical history review. Diagnostic procedures include:
Treatment Protocols: While there is no cure for Harada's disease, treatment aims to control inflammation, alleviate symptoms, and prevent vision loss. Typical management strategies include:
Clinical Advice & FAQs
Billing Guidance
Is H30.813 a billable ICD-10 code?
Yes, H30.813 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H30.813?
Clinical documentation must specify the nature of Harada's disease, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
